Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Immune-mediated inflammatory diseases (IMID), such as inflammatory bowel disease (IBD), multiple sclerosis (MS), and rheumatoid arthritis (RA), are highly prevalent in Canada and the United States and result in substantial personal and societal burden. The prevalence of psychiatric comorbidities, primarily depression and anxiety, in IMID exceeds those in the general population by two- to threefold, but remains underdiagnosed and undertreated. Furthermore, the effects of psychiatric comorbidity on IMID are not well understood. OBJECTIVE: The objectives of this study were (1) to compare health-related quality of life and work ability in persons with IMID and psychiatric comorbidity with those of persons with IMID without psychiatric comorbidity and with those of persons with depression and anxiety disorders alone, and (2) to validate existing case identification tools for depression and anxiety in persons with IMID to facilitate improved identification of depression and anxiety by clinicians. To achieve these objectives, we designed a prospective 3-year longitudinal study. In this paper, we aim to describe the study rationale and design and the characteristics of study participants. METHODS: Between November 2014 and July 2016, we recruited 982 individuals from multiple clinic and community sources; 18 were withdrawn due to protocol violations. RESULTS: The final study sample included 247 participants with IBD, 255 with MS, 154 with RA, and 308 with depression or anxiety. The majority were white, with the proportion ranging from 85.4% (IBD [210/246]; MS [217/254]) to 74.5% (114/153, RA; P=.01). There was a female predominance in all groups, which was highest in the RA cohort (84.4%, 130/154) and least marked in the IBD cohort (62.7%, 155/247). Participants with depression or anxiety were more likely to be single (36.0%, 111/308) than participants in any other group (11.8% [30/255]-22.7% [56/247], P<.001). CONCLUSIONS: This paper presents the rationale for this study, describes study procedures, and characterizes the cohort enrolled. Ultimately, the aim is improved care for individuals affected by IMID.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Screening for serious mental illness in the general population
Kessler, R. C., Barker, P. R., Colpe, L. J., Epstein, J. F., Gfroerer, J. C., Hiripi, E., Howes, M. J., Normand, S.-L. T., Manderscheid, R. W., Walters, E. E., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.2.184 · Cited by 5,692 · cited 3×
“In the general population, they share features of moderate to high sensitivity and specificity [62-68].”
Statistics notes: Cronbach's alpha: Table 1
Bland, J. M., & Altman, D. G. (1997) · BMJ · doi:10.1136/bmj.314.7080.572 · Cited by 5,300
Measuring Functioning and Well-Being: The Medical Outcomes Study Approach
Stewart, A., & Ware, J. (1992) · doi:10.7249/cb361 · Cited by 2,689
Pilkonis, P. A., Choi, S. W., Reise, S. P., Stover, A. M., Riley, W. T., Cella, D., & PROMIS Cooperative Group (2011) · Assessment · doi:10.1177/1073191111411667 · Cited by 2,132 · cited 4×
“In the general population, they share features of moderate to high sensitivity and specificity [62-68].”
InfluentialCognitive impairment in multiple sclerosis
Chiaravalloti, N. D., & DeLuca, J. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70259-x · Cited by 2,088
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Grant, B. F., Hasin, D. S., Chou, S. P., Stinson, F. S., & Dawson, D. A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1107 · Cited by 1,262 · cited 1×
“Individuals who reported ever smoking ≥100 cigarettes were defined as ever smokers [58] and were asked to report current smoking status (not at all, some days, every day), the age at which they had started smoking, how many cigarettes they currently smoked per day, and the number of days in the past 30 days that they…”
The changing demographic pattern of multiple sclerosis epidemiology
Koch-Henriksen, N., & Sørensen, P. S. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70064-8 · Cited by 1,191
Quality-of-Life Impairment in Depressive and Anxiety Disorders
Rapaport, M. H., Clary, C., Fayyad, R., & Endicott, J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1171 · Cited by 914 · cited 1×
“Psychiatric disorders are commonly associated with adverse health outcomes, including impaired HRQOL and missed work [12,13].”
Development and validation of an Overall Anxiety Severity and Impairment Scale (OASIS)
Norman, S. B., Hami Cissell, S., Means-Christensen, A. J., & Stein, M. B. (2006) · Depression and Anxiety · doi:10.1002/da.20182 · Cited by 770
Perceived Stress Scale: Reliability and Validity Study in Greece
Andreou, E., Alexopoulos, E. C., Lionis, C., Varvogli, L., Gnardellis, C., Chrousos, G. P., & Darviri, C. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8083287 · Cited by 641
Mikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000620 · Cited by 567 · cited 1×
“For the first aim, to test the baseline association between psychiatric comorbidity and either HRQOL or work disability in each IMID group, we assumed that at least 30% of the sample will experience any psychiatric comorbidity [95-97], confounders will explain 10% of the variation in the data, a 10% difference in HRQO…”
Self-citationLeung, D. Y., Lam, T.-H., & Chan, S. S. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-513 · Cited by 562 · cited 1×
“The 10-item version (PSS-10) has high internal consistency reliability and test-retest reliability, good construct validity, and predictive validity [71-74].”
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Marrie, R. A., Reingold, S., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., Cutter, G., & Reider, N. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514564487 · Cited by 519
Self-citationWalker, J. R., Ediger, J. P., Graff, L. A., Greenfeld, J. M., Clara, I., Lix, L., Rawsthorne, P., Miller, N., Rogala, L., McPhail, C. M., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01980.x · Cited by 437 · cited 1×
“For longitudinal analyses, we assumed an annual attrition rate of 3% [98], an average annual rate of decline of 3% in HRQOL and work impairment, a pooled between-group variance of 10, and a pooled within-group variance of 5.”
Self-citationPsychological Stress, Cytokine Production, and Severity of Upper Respiratory Illness
Cohen, S., Doyle, W. J., & Skoner, D. P. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199903000-00009 · Cited by 356 · cited 1×
“The 10-item version (PSS-10) has high internal consistency reliability and test-retest reliability, good construct validity, and predictive validity [71-74].”
Zhang, W., Bansback, N., Boonen, A., Young, A., Singh, A., & Anis, A. H. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3141 · Cited by 287
Anxiety and depression in patients with rheumatoid arthritis
Isik, A., Koca, S. S., Ozturk, A., & Mermi, O. (2007) · Clinical Rheumatology · doi:10.1007/s10067-006-0407-y · Cited by 276 · cited 1×
“For the first aim, to test the baseline association between psychiatric comorbidity and either HRQOL or work disability in each IMID group, we assumed that at least 30% of the sample will experience any psychiatric comorbidity [95-97], confounders will explain 10% of the variation in the data, a 10% difference in HRQO…”
Depression and cigarette smoking behavior: a critical review of population-based studies
Weinberger, A. H., Kashan, R. S., Shpigel, D. M., Esan, H., Taha, F., Lee, C. J., Funk, A. P., & Goodwin, R. D. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2016.1171327 · Cited by 263 · cited 13×
“The effects of psychiatric comorbidity on HRQOL and work ability in those with IMID, beyond the impact of the IMID itself, are not well understood.”
InfluentialAnderson, J. K., Zimmerman, L., Caplan, L., & Michaud, K. (2011) · Arthritis Care & Research · doi:10.1002/acr.20621 · Cited by 260
Arroll, B., Smith, F. G., Kerse, N., Fishman, T., & Gunn, J. (2005) · BMJ · doi:10.1136/bmj.38607.464537.7c · Cited by 230 · cited 1×
“Responses are “no,” “yes, but not today,” or “yes” [69].”
The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated
Marrie, R., Horwitz, R., Cutter, G., Tyry, T., Campagnolo, D., & Vollmer, T. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458508099477 · Cited by 219 · cited 1×
“Despite the adverse effects of depression and anxiety disorders on chronic disease outcomes, these psychiatric disorders are undertreated when they co-occur in IMID [22-26].”
Self-citationReilly, M. C., Gerlier, L., Brabant, Y., & Brown, M. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.02.016 · Cited by 196 · cited 1×
“In a clinical trial for IBD, the WPAI had adequate discriminative validity, reliability, and responsiveness [84]; it has good construct validity in RA [14], and it has been used in MS studies [15].”
Bennebroek Evertsz', F., Thijssens, N. A. M., Stokkers, P. C. F., Grootenhuis, M. A., Bockting, C. L. H., Nieuwkerk, P. T., & Sprangers, M. A. G. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2011.07.006 · Cited by 131
Retention strategies in longitudinal studies with emerging adults
Hanna, K. M., Scott, L. L., & Schmidt, K. K. (2014) · Clinical Nurse Specialist · doi:10.1097/nur.0000000000000020 · Cited by 72
Bhandari, S., Larson, M. E., Kumar, N., & Stein, D. (2017) · Gut and Liver · doi:10.5009/gnl16347 · Cited by 66
Cited by
The relationship between symptoms of depression and anxiety and disease activity in IBD over time
Marrie, R. A., Graff, L. A., Fisk, J. D., Patten, S. B., & Bernstein, C. N. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa349 · Cited by 128
Self-citationLewis, K., Marrie, R. A., Bernstein, C. N., Graff, L. A., Patten, S. B., Sareen, J., Fisk, J. D., Bolton, J. M., CIHR Team in Defining the Burden and Managing the Effects of Immune-Mediated Inflammatory Disease, Marrie, R. A., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz045 · Cited by 115
Self-citationComorbid anxiety, depression, and cognition in MS and other immune-mediated disorders
Whitehouse, C. E., Fisk, J. D., Bernstein, C. N., Berrigan, L. I., Bolton, J. M., Graff, L. A., Hitchon, C. A., Marriott, J. J., Peschken, C. A., Sareen, J., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000006854 · Cited by 112
“LikeMS, IBD and RA also share an increased prevalence of depression and anxiety as compared to the general population.1–3 Cognitive impairment is common in MS, affecting an estimated 40%–70% of individuals4; deficits in information processing speed are most often identified.5 Several studies suggest that comorbidities…”
BackgroundResultInfluentialSelf-citationPsychometric Performance of Fatigue Scales in Inflammatory Bowel Disease
Marrie, R. A., Fisk, J. D., Dolovich, C., Lix, L. M., Graff, L. A., Patten, S. B., & Bernstein, C. N. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad038 · Cited by 12
Self-citation
Metadata
- Authors
- Marrie, R. A., Graff, L., Walker, J. R., Fisk, J. D., Patten, S. B., Hitchon, C. A., Lix, L. M., Bolton, J., Sareen, J., Katz, A., Berrigan, L. I., Marriott, J. J., Singer, A., El-Gabalawy, R., Peschken, C. A., Zarychanski, R., & Bernstein, C. N.
- Venue
- JMIR Research Protocols
- Publisher
- JMIR Publications Inc.
- Published
- 2018-01-17
- Volume
- 7
- Issue
- 1
- Pages
- e15
- ISSN
- 1929-0748 (ISSN-L)
- OpenAlex
- W2783460893
- Cited by
- 53
- References
- 26
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.